Fujirebio Europe
Technologiepark 6
9052 Zwijnaarde
BE
Fujirebio Europe
Foundation date
18/07/1985
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
- #Diseases of the blood and blood-forming organs - immune disorders
- #Endocrine - nutritional and metabolic diseases
- #Infectious and parasitic diseases
- #Mental and behavioural disorders
- #Neoplasms / cancer / oncology
Fujirebio is a global leader in the field of high quality in vitro diagnostics (IVD) testing. It has more than 50 years’ accumulated experience in the conception, development, production and worldwide commercialization of robust IVD products.Fujirebio has a strong and long-lasting tradition of collaborating with experts in the worldwide clinical community in the development of high-quality routine and truly novel biomarkers that cover a variety of disease states.
Upcoming events
All events-
0411 '24
BIO-Europe® 2024 - 30th Annual International Partnering Conference
Event by: EBD Group -
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0312 '24
BioFIT 2024
Event by: Eurasanté
Latest news
More news-
Biotalys Appoints Kamal El Mernissi as Chief Business Development Officer
Thursday October 17th 2024
Read more
-
InnoSer Announces Joint Initiative with Hasselt University/BIOMED to Support Preclinical Multiple Sclerosis Research
Wednesday October 16th 2024
Read more
-
A brown ale or hoppy lager? Even fruit flies have a preference.
Tuesday October 15th 2024
Read more
Jobs
More jobsMore info?
Ellen Telleir
Communication Coordinator